Conversely, miR-29 suppresses PCK1 by targeting its 3’ untranslated region (UTR) for mRNA degradation, impairing gluconeogenic capacity—a mechanism implicated in metabolic syndrome pathogenesis where miR-29 overexpression correlates with insulin resistance16,17. The gene discussed is PCK1; the disease is metabolic syndrome.